尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Rubin Gary D. Director active across 1 company, notably bioAffinity Technologies, Inc.. Cumulatively, 5 reports have been recorded. Activity tracked since 6 September 2022. The latest transaction was disclosed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Rubin Gary D is a Director at bioAffinity Technologies, Inc. He has 5 filings in total, and across the 5 recent filings available, the transactions run from 2022-10-21 to 2024-07-02, with buy volume of EUR 0 and sell volume of EUR 0; the modal transaction nature is Attribution.